Navigation

Dyloject

Dyloject (Diclofenac Sodium for Injection) side effects drug center

 

PROFESSIONAL

SIDE EFFECTS

 

Dyloject Side Effects Center

What Is Dyloject?

Dyloject (diclofenac sodium) for Injection is a nonsteroidal anti-inflammatory drug (NSAID) used for management of mild to moderate pain and management of moderate to severe pain alone or in combination with opioid analgesics.

What Are Side Effects of Dyloject?

Common side effects of Dyloject include:

Dosage for Dyloject?

The recommended dose of Dyloject is 37.5 mg administered by intravenous bolus injection over 15 seconds every 6 hours as needed, not to exceed 150 mg/day.

What Drugs, Substances, or Supplements Interact with Dyloject?

Dyloject may interact with aspirin, anticoagulants, or ACE inhibitors. Tell your doctor all medications and supplements you use.

Dyloject During Pregnancy and Breastfeeding

During pregnancy, use only if approved by your obstetrician and avoid use of Dyloject after 30 weeks. It may harm a fetus. This drug may pass into breast milk. Consult your doctor before breastfeeding.

Additional Information

Our Dyloject (diclofenac sodium) for Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

 

Dyloject Professional Information

SIDE EFFECTS

The following adverse reactions are discussed in greater detail in other sections of the labeling:

Clinical Trials Experience

Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.

During clinical development, 1,156 patients were exposed to DYLOJECT in multiple-dose, controlled and open-label studies. DYLOJECT was administered post-surgically every 6 hours for up to 5 days. The incidence rates of adverse reactions listed in the following table are derived from multicenter, controlled clinical studies in post-operative patients comparing DYLOJECT to placebo in patients who may have also received morphine rescue medication.

Table 1: Proportion of Patients Experiencing Common Adverse Reactions in Placebo-Controlled Clinical Studies in Patients with Acute Moderate-to-Severe Postoperative Pain occurring in greater than or equal to 3% in patients treated with DYLOJECT

MedDRA Preferred Term Placebo*
N=126		 DYLOJECT*
N=187
Any Reaction 104 (83%) 146 (78%)
Nausea 50 (40%) 45 (24%)
Constipation 14 (11%) 25 (13%)
Headache 20 (16%) 19 (10%)
Infusion Site Pain 10 (8%) 19 (10%)
Dizziness 2 (2%) 15 (8%)
Flatulence 20 (16%) 15 (8%)
Vomiting 23 (18%) 12 (6%)
Insomnia 12 (10%) 11 (6%)
Pruritus 10 (8%) 9 (5%)
Hypotension 6 (5%) 9 (5%)
Pyrexia 13 (10%) 8 (4%)
Anemia 9 (7%) 8 (4%)
Infusion Site Extravasation 1 (1%) 6 (3%)
* Intravenous morphine was permitted as rescue medication for pain management.
Adverse Reactions Of Special Interest

Based on the analysis of the pooled data from the multi-dose, controlled clinical trials, post-operative patients treated with DYLOJECT had more adverse reactions related to wound healing (7.5%) compared to patients treated with placebo (4%).

Adverse Reactions From Clinical Studies Or Spontaneous Reports For Other Formulations Of Diclofenac And Other NSAIDs

In patients taking diclofenac or other NSAIDs, the most frequently reported adverse reactions occurring in approximately 1%-10% of patients are:

Gastrointestinal experiences including abdominal pain, constipation, diarrhea, dyspepsia, flatulence, gross bleeding/perforation, heartburn, nausea, GI ulcers (gastric/duodenal) and vomiting. Abnormal renal function, anemia, dizziness, edema, elevated liver enzymes, headaches, increased bleeding time, pruritus, rashes and tinnitus.

Additional adverse reactions reported occasionally include:

Body as a Whole: fever, infection, sepsis

Cardiovascular System: congestive heart failure, hypertension, tachycardia, syncope

Digestive System: esophagitis, gastric/peptic ulcers, gastritis, gastrointestinal bleeding, glossitis, hematemesis, hepatitis, jaundice

Hemic and Lymphatic System: ecchymosis, eosinophilia, leukopenia, melena, purpura, rectal bleeding, stomatitis, thrombocytopenia

Metabolic and Nutritional: weight changes

Nervous System: anxiety, asthenia, confusion, depression, dream abnormalities, drowsiness, insomnia, malaise, nervousness, paresthesia, somnolence, tremors, vertigo

Respiratory System: asthma, dyspnea

Skin and Appendages: alopecia, photosensitivity, sweating increased

Special Senses: blurred vision

Urogenital System: cystitis, dysuria, hematuria, interstitial nephritis, oliguria/polyuria, proteinuria, renal failure

Other adverse reactions, which occur rarely are:

Body as a Whole: anaphylactic reactions, appetite changes, death

Cardiovascular System: arrhythmia, hypotension, myocardial infarction, palpitations, vasculitis

Digestive System: colitis, eructation, fulminant hepatitis with and without jaundice, liver failure, liver necrosis, pancreatitis

Hemic and Lymphatic System: agranulocytosis, hemolytic anemia, aplastic anemia, lymphadenopathy, pancytopenia

Metabolic and Nutritional: hyperglycemia

Nervous System: convulsions, coma, hallucinations, meningitis

Respiratory System: respiratory depression, pneumonia

Skin and Appendages: angioedema, toxic epidermal necrolysis, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, urticaria

Special Senses: conjunctivitis, hearing impairment

Read the entire FDA prescribing information for Dyloject (Diclofenac Sodium for Injection)

&Copy; Dyloject Patient Information is supplied by Cerner Multum, Inc. and Dyloject Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.